Media Newsroom of

Vesalius Cardiovascular

Follow on Social Network
2525 Willow Street (506)
Vancouver, BC V5Z3N8
Vesalius Cardiovascular

Vesalius Cardiovascular is a Canadian MedTech based in Vancouver. The team specializes in novel therapies for structural heart disease, specifically mitral valve regurgitation. The company is current pre-clinical.

Vesalius Cardiovascular Reaches a New and Advanced Pre-Clinical Milestone

Vesalius Cardiovascular Reaches a New and Advanced Pre-Clinical Milestone

Vesalius Cardiovascular Inc. (VCI), a Canadian MedTech company developing a Transfemoral Mitral Valve Repair (TMVr) solution, announced today the achievement of a new pre-clinical milestone with its 180-day chronic animal study. The predetermined endpoints of the study were the feasibility…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login